000 01467 a2200397 4500
005 20250517113650.0
264 0 _c20170213
008 201702s 0 0 fre d
022 _a1769-6658
024 7 _a10.1016/j.canrad.2016.07.093
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aFourquet, A
245 0 0 _a[Normofractionated breast irradiation in breast cancer. Indications and benefits].
_h[electronic resource]
260 _bCancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique
_cOct 2016
300 _a564-6 p.
_bdigital
500 _aPublication Type: Journal Article; Review
650 0 4 _aBreast Carcinoma In Situ
_xradiotherapy
650 0 4 _aBreast Neoplasms
_xradiotherapy
650 0 4 _aCarcinoma, Ductal, Breast
_xradiotherapy
650 0 4 _aDose Fractionation, Radiation
650 0 4 _aFemale
650 0 4 _aFibrosis
_xetiology
650 0 4 _aHumans
650 0 4 _aLung
_xpathology
650 0 4 _aMastectomy, Segmental
650 0 4 _aMyocardium
_xpathology
650 0 4 _aNeoplasm Recurrence, Local
650 0 4 _aOrgans at Risk
650 0 4 _aRadiotherapy, Adjuvant
700 1 _aKrhili, S-L
700 1 _aCampana, F
700 1 _aChilles, A
700 1 _aKirova, Y-M
773 0 _tCancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique
_gvol. 20
_gno. 6-7
_gp. 564-6
856 4 0 _uhttps://doi.org/10.1016/j.canrad.2016.07.093
_zAvailable from publisher's website
999 _c26387734
_d26387734